When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective.

Saved in:
Bibliographic Details
Title: When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective.
Authors: Parisi MA; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA., Caggana M; Wadsworth Center, New York State Department of Health, Division of Genetics, Albany, New York, USA., Cohen JL; Duke University School of Medicine, Durham, North Carolina, USA., Gold NB; Massachusetts General Hospital for Children, Boston, Massachusetts, USA., Morris JA; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Orsini JJ; New York State Department of Health, Wadsworth Center, Albany, New York, USA., Urv TK; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA., Wasserstein MP; Albert Einstein College of Medicine and the Children's Hospital at Montefiore, Bronx, New York, USA.
Source: American journal of medical genetics. Part C, Seminars in medical genetics [Am J Med Genet C Semin Med Genet] 2023 Mar; Vol. 193 (1), pp. 44-55. Date of Electronic Publication: 2023 Mar 06.
Publication Type: Review; Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101235745 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4876 (Electronic) Linking ISSN: 15524868 NLM ISO Abbreviation: Am J Med Genet C Semin Med Genet Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1552-4876
DOI:10.1002/ajmg.c.32036